Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

BLADDER CANCER

Secondary malignancy after radiotherapy: not always a secondary concern

Nature Reviews Urology volume 18, pages 513–514 (2021)Cite this article

Subjects

Radiotherapy is one of the most effective modalities for cancer treatment, but radiation-associated secondary malignancies are important potential morbidities. Here, we highlight a recent article that examines radiation-associated muscle-invasive bladder cancer and explore how we as clinicians should consider the management of secondary malignancies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Parker, R. G. Radiation-induced cancer as a factor in clinical decision making (the 1989 ASTRO Gold Medal Address). Int. J. Radiat. Oncol. Biol. Phys. 18, 993–1000 (1990).

    Article  CAS  Google Scholar 

  2. Hall, E. J. & Wuu, C.-S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int. J. Radiat. Oncol. Biol. Phys. 56, 83–88 (2003).

    Article  Google Scholar 

  3. Eaton, B. R., MacDonald, S. M., Yock, T. I. & Tarbell, N. J. Secondary malignancy risk following proton radiation therapy. Front. Oncol. 5, 261 (2015).

    Article  Google Scholar 

  4. Schneider, U. et al. The impact of IMRT and proton radiotherapy on secondary cancer incidence. Strahlenther. Onkol. 182, 647–652 (2006).

    Article  Google Scholar 

  5. Sha, S. T. et al. Clinical characterization of radiation-associated muscle-invasive bladder cancer. Urology https://doi.org/10.1016/j.urology.2021.03.033 (2021).

    Article  PubMed  Google Scholar 

  6. Goldberg, Z. Clinical implications of radiation-induced genomic instability. Oncogene 22, 7011–7017 (2003).

    Article  CAS  Google Scholar 

  7. Dores, G. M. et al. Second malignant neoplasms among long-term survivors of Hodgkin’s disease: a population-based evaluation over 25 years. J. Clin. Oncol. 20, 3484–3494 (2002).

    Article  Google Scholar 

  8. Lee, C.-L. et al. Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma. JCI Insight 4, e128698 (2019).

    Article  Google Scholar 

  9. Yamamoto, S. et al. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident. Cancer Res. 59, 3606–3609 (1999).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA

    Vishruth K. Reddy & Neha Vapiwala

Authors
  1. Vishruth K. Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neha Vapiwala
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neha Vapiwala.

Ethics declarations

Competing interests

The authors declare no competing interests

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reddy, V.K., Vapiwala, N. Secondary malignancy after radiotherapy: not always a secondary concern. Nat Rev Urol 18, 513–514 (2021). https://doi.org/10.1038/s41585-021-00486-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41585-021-00486-w

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing